VITRO DIAGNOSTICS INC
10QSB/A, EX-27, 2000-06-28
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: VITRO DIAGNOSTICS INC, 10QSB/A, EX-99, 2000-06-28
Next: KLLM TRANSPORT SERVICES INC, SC TO-T/A, 2000-06-28



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This  schedule  contains  summary  financial   information  extracted  from  the
Statement  of  Financial  Condition  at January  31,  2000  (Unaudited)  and the
Statement of Income for the Quarter  Ended January 31, 2000  (Unaudited).  It is
qualified in its entirety by reference to such financial statements.

</LEGEND>

<S>                                       <C>
<PERIOD-TYPE>                           3-MOS
<FISCAL-YEAR-END>                       Oct-31-2000
<PERIOD-END>                            Jan-31-2000
<CASH>                                       28,132
<SECURITIES>                                      0
<RECEIVABLES>                               242,792
<ALLOWANCES>                                      0
<INVENTORY>                                 188,267
<CURRENT-ASSETS>                            515,567
<PP&E>                                      219,838
<DEPRECIATION>                              149,529
<TOTAL-ASSETS>                              736,550
<CURRENT-LIABILITIES>                       215,061
<BONDS>                                           0
<COMMON>                                    283,036
                             0
                                       0
<OTHER-SE>                                        0
<TOTAL-LIABILITY-AND-EQUITY>                736,549
<SALES>                                     269,242
<TOTAL-REVENUES>                            269,242
<CGS>                                       163,434
<TOTAL-COSTS>                               142,759
<OTHER-EXPENSES>                            309,324
<LOSS-PROVISION>                                  0
<INTEREST-EXPENSE>                                0
<INCOME-PRETAX>                          (3,062,091)
<INCOME-TAX>                                      0
<INCOME-CONTINUING>                               0
<DISCONTINUED>                                    0
<EXTRAORDINARY>                                   0
<CHANGES>                                         0
<NET-INCOME>                             (3,062,091)
<EPS-BASIC>                                  (.04)
<EPS-DILUTED>                                  0.03



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission